Comment suivre un patient sous immunoglobulines intraveineuses pour une neuropathie dysimmunitaire ?

Intravenous immunoglobulins form the cornerstone of treatment of inflammatory neuropathies. Usually requiring a chronic use, this medication requires a good knowledge of the precautions, the dose to use, and evaluation of the clinical benefit obtained by a standardized clinical examination.